Effects of Interferon β-1a and Interferon β-1b Monotherapies on Selected Serum Cytokines and Nitrite Levels in Patients with Relapsing-Remitting Multiple Sclerosis: A 3-Year Longitudinal Study

Publisher： Karger

E-ISSN： 1423-0216|20|4|213-222

ISSN： 1021-7401

Source： Neuroimmunomodulation, Vol.20, Iss.4, 2013-05, pp. : 213-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon β-1a Induces Tumor Necrosis Factor Receptor 1 but Decreases Tumor Necrosis Factor Receptor 2 Leukocyte mRNA Levels in Relapsing-Remitting Multiple Sclerosis

By  

Neuroimmunomodulation, Vol. 16, Iss. 3, 2009-02 ,pp. : 171-176

Karger

Access to resources Recommend Favorite

Interferon-β 1a Modulates Expression of RAGE but Not S100A12 and Nuclear Factor-κB in Multiple Sclerosis Patients

By  

Neuroimmunomodulation, Vol. 23, Iss. 5-6, 2017-04 ,pp. : 345-351

Karger

Access to resources Recommend Favorite

Quantitative MRI and Cerebrospinal Fluid Inflammatory Mediators in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis before and after Treatment with Immunomodulators: A Longitudinal Study

By  

Neuroimmunomodulation, Vol. 19, Iss. 5, 2012-03 ,pp. : 277-282

Karger

Access to resources Recommend Favorite

Interleukin-17A Levels Vary in Relapsing-Remitting Multiple Sclerosis Patients in Association with Their Age, Treatment and the Time of Evolution of the Disease

By  

Neuroimmunomodulation, Vol. 23, Iss. 1, 2015-11 ,pp. : 8-17

Karger

Access to resources Recommend Favorite

TRAF2 is Upregulated in Relapsing-Remitting Multiple Sclerosis

By  

Neuroimmunomodulation, Vol. 20, Iss. 3, 2013-04 ,pp. : 177-183

Karger

Access to resources Recommend Favorite